Showing results (291-300 of 329) with videos related to

Sort By:
Pageof 33
Circulation|November 13, 2020
Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular DiseaseJohn J V McMurray, David C Wheeler, Bergur V Stefánsson, et al.
Nature Medicine|August 20, 2020
Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in ChinaXin Xu, Jian Sun, Sheng Nie, et al.
JACC. Heart Failure|June 30, 2022
Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart FailureJ David Smeijer, Jeroen Koomen, Donald E Kohan, et al.
Clinical Kidney Journal|August 12, 2024
Inverse association between serum chloride levels and the risk of atrial fibrillation in chronic kidney disease patientsYangang Gan, Sheng Nie, Mingzhen Pang, et al.
Clinical Pharmacology and Therapeutics|July 27, 2022
Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney DiseaseJ David Smeijer, Jeroen V Koomen, Donald E Kohan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2019
Visit-to-visit variability in blood pressure and the development of chronic kidney disease in treated general hypertensive patientsYoubao Li, Dan Li, Yun Song, et al.
Nature Medicine|June 7, 2020
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in ChinaXin Xu, Jian Sun, Sheng Nie, et al.
Lancet (London, England)|April 19, 2019
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trialHiddo J L Heerspink, Hans-Henrik Parving, Dennis L Andress, et al.
Pageof 33